New books


Viewing: 1 - 4 of 4
Published:
May 02, 2013
Author(s):
Sin-Ho Jung
In cancer research, a traditional phase II trial is designed as a single-arm trial that compares the experimental therapy to a historical control. This simple trial design has led to several adverse issues, including increased false positivity of phase II trial results and negative phase III trials 
  Hardback
$89.95
Add to cart
Published:
April 17, 2013
Editor(s):
James Mittra; Christopher-Paul Milne
This book brings together a range of academic, industry and practitioner perspectives on translational medicine (TM). It enhances conceptual and practical understanding of the emergence and progress of the field and its potential impact on basic research, therapeutic development, and institutional 
  Hardback
$149.95
Add to cart
Published:
April 09, 2013
Editor(s):
Pritam Sahota; James A. Popp; Jerry F. Hardisty; Chirukandath Gopinath
As drug development shifts over time to address unmet medical needs and more targeted therapies are developed, previously unseen pharmacological or off-target effects may occur in treatment. Designed to provide practical information for the bench toxicologic pathologist working in 
  Hardback
$259.95
Add to cart
Published:
March 13, 2013
Author(s):
Robert S. Matson
Microarrays play an increasingly significant role in drug discovery. The commercial landscape has changed dramatically over the past few years and researchers have made great advancements with regard to construction and use. Now in its second edition, Applying Genomic and Proteomic Microarray 
  Hardback
$149.95
Add to cart

Textbooks
Other CRC Press Sites
Featured Authors
STAY CONNECTED
Facebook Page for CRC Press Twitter Page for CRC Press You Tube Channel for CRC Press LinkedIn Page for CRC Press Google Plus Page for CRC Press
Sign Up for Email Alerts
© 2013 Taylor & Francis Group, LLC. All Rights Reserved. Privacy Policy | Cookie Use | Shipping Policy | Contact Us